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ABSTRACT
hest wall tumours account for 5% of all thoracic 
malignancy and vary widely in pathology. This  Cis because  they arise from a range of cell types 
which including soft tissue, bone and cartilage as well 
as metastatic disease, each with different growth 
potentials, presentations, diagnostic properties and 
1,2,3,4,5
prognosis.  Although chest wall is not an organ, it 
functions as a fundamental unit with complex 
interplay between soft tissue, bone and cartilage in 
protecting thoracic and abdominal viscera and 
providing integrity of respiratory function. 
Primary chest wall tumours occur in the 5th and 6th 
decade of life with equal gender distribution and with 
6
equal possibility of either being malignant or benign . 
More than 50% of chest wall tumours are malignant 
and typically are secondaries, either as invasive from 
7
neighboring structures or metastatic in nature .
Pain and mass are the ways chest wall tumours 
8
present . Some are found incidentally on chest x-rays 
9,10
while others are asymptomatic . Radiologic imaging 
is important in the assessment of these tumours 
especially in determining anatomic origin, extent of 
response to treatment and recurrence. Chest X-ray can 
be used to determine the location, size, growth rate of 
the mass as well as to detect calcification, ossification or 
11
bone involvement . Computerized tomography 
enables more accurate assessment of tumour 
morphology, composition, location and extent of soft 
12
tissue involvement . 
INTRODUCTION
BACKGROUND/OBJECTIVE:  Chest wall tumours are not uncommon. They are regarded as malignant until 
otherwise proven. The objective of this study is to analyze the histological variants in our institution and compare 
same with relevant data available in the literature. 
Materials and Methods:  We performed a retrospective study of chest wall tumours at our institution(NCTCE, 
UNTH, Enugu, Nigeria), for a period of 15 years, spanning October, 2001 to September, 2015. The pathologic 
reports were retrieved from the hospital pathology archives and correlated with patients' copies in the hospital 
record. The lesions were classified as primary and secondary based on the clinical and radiological data as well as 
the histological reports.
RESULTS: A total of 158 chest wall tumours were identified in 158 patients with a mean age range of (45 +/- 6). 
The male to female ratio was 1:1.1(male = 74, 46.84% and female =84, 53.16%).  There were 81 primary chest wall 
tumours, out of which benign soft chest wall tumour was 50(61.73%) and malignant soft chest wall tumour was 
13(16.05%). The benign bone and cartilage chest wall tumour accounted for 1(1.23%) and malignant component 
was 17(20.99%). The secondary chest wall tumours studied were 77, out of which 30(38.96%) were invasive and 
47(61.04%) were metastatic 
CONCLUSION: The commonest primary malignant chest wall tumour was malignant fibrous histocytoma while 
the most common secondary chest wall tumours seen in this study was mostly metastatic epithelial neoplasms.
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The mean age was 50.0 years (range is 3-97 years). The 
highest age range affected was 51-60 years, with n=43 
(24.71%), followed by 31-40 years, with n=40 (22.99%). 
The lowest age range was 81-90 years with n=0, 
(0.00%), followed by 91-100 years with n=1 (0.58%), see 
figure 1.
Figure 1: Showing age range of patients
There were 158 histopathological slides, out of which 
81 (51.27%) were primary tumours of the chest wall and 
77 (48.73%) were secondary chest wall tumours.  
Within the primary chest wall tumours, benign soft 
tissue was 50(61.73%) while the malignant soft tissue 
was 13 (16.05%). The benign bone and cartilage soft 
tissue was 1 (1.23%) while malignant bone and cartilage 
was 17(20.99%). Among the secondary chest wall 
tumours, invasive was 30 (38.96%) while metastatic 
was 47 (61.04%).
Figure 2: showing the distribution of primary benign 
soft tissue chest wall tumours
 
Within benign group of the soft tissue chest wall 
tumours, lipoma was the highest, n=42 (84.00%), 
followed by carvenous haemangioma with n = 3 
(6.00%). See figure 2. Among the malignant soft tissue 
tumours, malignant fibrous histiocytoma was the 
highest, with n = 5 (38.46%), followed by 
rhabdomyosarcoma, with n = 4 (30.77%), See figure 3. 
Within malignant bone and cartilage chest wall 
tumours, multiple myeloma was the highest with n = 8 
(53.33%) followed by chondrosarcoma with n = 49 
(26.67%). Also see figure 4. We recorded only 1 
Though, radiologic evaluations are   useful in 
determining tumour invasion, surgical treatment 
planning and follow up, their features are 
12,13,14,nonspecific . Histology provides the supreme 
court of diagnosis. Tru-cut biopsy, excisional and 
incisional biopsies are the commonest methods 
employed. The use of fine needle aspiration cytology is 
4 , 6 , 1 1 , 1 5controversial .  Cytologic  specimen is  
unsatisfactory and the use of the results obtained 
therefrom leads to inadequate treatment and worse 
16,17prognosis .
Surgical extirpation with or without reconstruction, 
chemo-radiation and physiotherapy are the common 
modalities of treating chest wall tumours. Decision of 
choice is governed by the size of the tumour, extent of 
resection, the need for reconstruction and associated 
co-morbidity. Patients with extensive or complicated 
lesion are best served with a multidisciplinary 
18approach . Resection prolongs survival and also is a 
19palliation for symptomatic lesions .
Materials and Methods
We performed a retrospective study of chest wall 
tumours at our institution National Cardiothoracic 
Center of Excellence (NCTCE), University of Nigeria 
Teaching Hospital(UNTH) Ituku-Ozalla,Enugu for a 
period of 15 years, spanning October, 2001 to 
September, 2015. The pathologic reports were retrieved 
from the hospital pathology archives and correlated 
with patients' copies in the hospital record.  Clinical 
and radiological data were obtained through a review 
of hospital records of these patients. The lesions were 
classified as primary and secondary based on the 
clinical and radiological data as well as the 
histopathological reports and in some cases, 
immunohistochemical findings. There were 158 
histopathological reports from the morbid anatomy 
department and 158 of them were correlated with the 
patients' database in the Health Information 
Technology Department.
The tumours were further subdivided into different 
groups as: (1) soft tissue, bone and cartilage or 
haematologic or lymphomas (2) benign or malignant, 
(3) primary or secondary and finally (4), the secondary 
was subdivided into invasive or metastatic. 
Data were analyzed using SPSS version 16(Chicago). 
Rates and proportions were calculated with 95% 
confidence interval (CI). The proportions were 
compared using students't- tests. Level of significance 
was set at P < 0.05.
Results
There were 158 patients, with 74 males (47.13%) and 84 
females (52.87%). The male to female ratio was 1:1.1. 
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Figure 6: Showing the distribution of metastatic 
secondary chest wall tumours
The commonest histologic types were carcinomas 
(64.27%) followed by mesotheliomas(20.31%) and 
melanomas(5.45%). Among the metastatic tumours, 
40.42% had unknown primary sites even after 
immunohistochemical staining.
a. Multiple myeloma 
chondroma as a benign bone and cartilage tumour.
Figure 3: Showing the distributions of the primary 
malignant soft tissue chest wall tumours
Figure 4: Showing the distribution of primary 
malignant bone and cartilage chest wall tumours.
Of about 108 cases of malignant chest wall tumours in 
our study, 77 (71.30%) were metastases from distant 
organs or direct invasion from adjacent structures. The 
primary sites for both the invasive and metastatic 
tumours are shown in figures 5 and 6.
Figure 5: Showing the distributions of invasive 
secondary chest wall tumours
b   chondrosarcoma 




Chest wall tumours account for 1-2% of all tumours; 
2060% are malignant . These neoplasms can be primary 
soft tssue, bone and cartilage or may be metastasis from 
21adjacent or distant structures or organs . In this study, 
we noted the heterogenous distributions of the 
tumours according to the structures that make up the 
chest wall, which are soft and bony-cartilaginous 
tissues. Among the benign soft tissues, histologically, 
lipoma was the commonest accounting for 84.00%. This 
22finding is in agreement with other studies . Lipomas of 
chest wall are usually well circumscribed and situated 
deep. This was closely followed by haematologic 
tumours: carvenous haemangioma and haemangioma 
with 6.00% and 4.00% respectively. Carvenous 
haemangioma is sharply defined but not encapsulated 
and made up of large, carvenous vascular spaces, 
partly or incompletely filled with blood separated by a 
scant connective tissue stroma. 
In the primary malignant soft tissue tumour of the chest 
wall, we observed malignant fibrous histiocytoma as 
the most common (38.46%), closely followed by 
rhabdomyosarcoma (30.77%).  Others  were 
f i b r o s a r c o m a  ( 1 5 . 3 9 % ) ,  l y m p h o b l a s t i c  
lymphoma(7.69%) and unclassified sarcoma(7.69%). In 
the literature, malignant fibrous histiocytoma was the 
23most common soft tissue sarcoma  and is also reported 
7to be rare in the chest region . Our study however, 
22agrees with that of Mohammadtaher et al . MFH have 
been categorized into storiform-p[eomorphic, myxoid, 
inflammatory, giant cells and amngiomatoid variants 
24based on histologic features . The storiform-
pleomorphic was most common, about 65% and as the 
name indicates is composed of malignant spindle cells 
orientated in a storiform pattern, with scattered large, 
round pleomorphic cells. Rhabdomyosarcoma is a 
malignant tumour of a skeletal muscle. Histologically, 
it is classified into embryonal, alveolar and 
pleomorphic(adult form). Others occur in children, 
25adolescent and young adults . We recorded 
unclassified sarcoma as 7.69% of all primary malignant 
soft tissue tumours of the chest wall. Other studies have 
estimated the prevalence of unclassified sarcoma as 
about 1% of sarcomas of the chest wall in adults and 
2610% in infants and children .
Among the primary malignant bone and cartilage 
tumours of the chest wall, we observed in our study 
that multiple myeloma was the most common(53.33%), 
fol lowed by chondrosarcoma (26.6%) and 
osteosarcoma (20.00%). Other studies are at variance 
with our observation, in that Chondrosarcoma was the 
commonest primary malignant bone and cartilage 
1, 19, 27, 28,tumours of the chest in their studies . 
Figure 7: Note that most of the patients involved in the 
study did present late as can be seen in this figure. A 
t y p i c a l  a p p e a r a n c e  o f  c h o n d r o m a  a n d  
chondrosarcoma is depicted in figure 8.
d. Intrathoracic chest wall tumour(osteosarcoma), 
simulating thoracic outlet syndrome
a.  Chondroma                  b. chondrosarcoma
Figure 8.
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Solitary myeloma and multiple myeloma are plasma 
cell tumours that manifest respectively as a single mass 
or with diffuse bone marrow involvement. There was 
no observation of solitary myeloma in our study but 
etra- osseous solitary myeloma which manifests as a 
nonspecific soft- tissue mass  that progresses less 
29frequently to multiple myeloma . Chondrosarcoma is 
morphologically subclassified into conventional 
i n t r a m e d u l l a r y ,  j u x t a c o r t i c a l ,  c l e a r  c e l l ,  
30,31dedifferentiated and mesenchymal variants . Well 
differentiated chondrosarcoma may morphologically 
resemble chondroma. Chonrdoma in the chest wall is 
32very rare . We observed only one case in 15 years.
Invasion and metastasis are biologic hallmarks of 
malignant tumours. They are the major cause of cancer 
24,33,34related morbidity and mortality.  In this study, 
secondary chest wall tumours constituted the most 
significant proportion of disease. Of all the 107 
malignant chest wall tumours studied, 77(71.96%) 
were secondary tumours. Within the secondary chest 
wall tumours, invasive and metastatic tumours were 
38.96% and 61.04% respectively. This observation is in 
agreement with other study which showed that 
secondary chest wall tumours comprised most of the 
35malignant types . The primary sites of both 
invasive and metaststic tumours are shown in figures 5 
& 6. The histologic types were carcinomas, 
mesotheliomas and melanomas in decreasing order.
CONCLUSION
Lipoma was the most common primary benign chest 
wall tumour, while malignant fibrous histiocytoma 
and multiple myeloma constituted the most common 
primary malignant soft and bony-cartilaginous tissues 
respectively. Overall, secondary chest tumours were 
the dominant malignant chest wall tumours in our 
study. There was equal gender predispodition.
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